U.S., July 1 -- ClinicalTrials.gov registry received information related to the study (NCT07675330) titled 'Oxymetazoline Versus Sodium Hypochlorite as Hemostatic Agents in MTA Pulpotomy of Primary Molars' on June 23.
Brief Summary: This study aims to evaluate clinical and radiographic success of oxymetazoline versus sodium hypochlorite as hemostatic agents in MTA pulpotomy of primary molars.
Study Start Date: Aug., 2026
Study Type: INTERVENTIONAL
Condition:
Pulp Disease, Dental
Pulp Therapy in Primary Molars
Pulpitis - Reversible
Pulp Inflammation
Vital Pulp Therapies
Carious Exposure of Pulp
Primary Molar Tooth
Primary Molar Pulpotomy
Intervention:
OTHER: Oxymetazoline 0.05% nasal solution
Using 1 drop (~0.05 mL) of 0.05% OXY (Nor...